This test is most useful if any of these apply to you.
When your body senses a serious threat, your bone marrow rushes young, half-finished white blood cells into circulation before they are fully ready. These cells are immature granulocytes (IGs), and their presence in your blood is a signal that something is pushing your immune system harder than usual.
Most standard blood panels report total white blood cells without breaking out these younger forms. Modern analyzers can now count them automatically, giving you an early read on bacterial infection, sepsis risk, and inflammatory burden that a basic white count can miss.
Granulocytes are the foot soldiers of your immune system. They mature in the bone marrow through several stages (promyelocytes, myelocytes, and metamyelocytes) before becoming the mature neutrophils that fight infection. Under normal conditions, those younger forms stay in the marrow. When demand spikes, the marrow ships them out early, a phenomenon doctors call a left shift.
Automated hematology analyzers count these young cells and report them two ways: as an absolute number (IG count) and as a percentage of total white blood cells (IG percent). A small number circulate in healthy people. A meaningful rise points to bone marrow activation, usually from infection, severe inflammation, tissue injury, or, less often, a marrow disorder.
The strongest evidence for this test sits in the world of infection. In critically ill adults, IG percent above 3% is highly specific for sepsis, and IG percent performs comparably to C-reactive protein (CRP, a general inflammation marker) for predicting infection and septic shock. When combined with white blood cell count and CRP, IG percent adds extra signal for ruling infection in or out.
In a study of 137 hospitalized adults, IG count and IG percent were the earliest biomarkers to rise in patients who went on to develop sepsis. In a study of 301 patients, IG percent showed 90.9% specificity at a 2.0% cutoff, meaning an elevated value strongly pointed toward sepsis. In severe burn patients, an IG percent cutoff of about 3% identified sepsis with 76.9% sensitivity and 68.1% specificity.
What this means for you: if you are working up a possible infection, an elevated IG count gives an early, low-cost signal that the immune system is mobilizing harder than a standard white count alone might suggest. It does not diagnose infection by itself, but it raises the index of suspicion and can shorten the time to treatment.
Beyond detection, IG measurements track how sick someone is. In ICU sepsis patients, day-three IG count and IG percent are higher when antibiotic therapy is not working and are linked to higher 28-day mortality. The delta neutrophil index (a related left-shift measure) above 6.5% predicted severe sepsis or septic shock with 81.3% sensitivity and 91.0% specificity.
In acute pancreatitis, higher IG percent associates with more severe disease, acute respiratory distress syndrome, and in-hospital death, with one study including 1,933 patients finding IG percent to be a novel predictor of respiratory failure. In 213 patients with upper gastrointestinal bleeding, IG count and IG percent were significant predictors of 30-day mortality. In 70 intracerebral hemorrhage patients, higher IG count tracked with 30-day mortality. In 146 patients with ST-elevation heart attack, elevated IG levels marked higher mortality risk.
In 78 patients with acute coronary syndrome, IG levels predicted a higher coronary SYNTAX score, a measure of how complex and severe coronary artery disease is. In 210 patients with stable decompensated cirrhosis, higher IG count and IG percent were associated with worse survival. In 158 fibromyalgia patients, IG levels were elevated compared with controls, suggesting a low-grade inflammatory phenotype that standard inflammation markers may miss.
These findings extend the use of IG beyond pure infection territory. The pattern is consistent: when IG levels climb in someone with chronic disease, the prognosis tends to be worse, and tracking the trend over time gives information that a static white count does not.
In one published study, IG measurement was a better predictor of infection than total white blood cell count and comparable to absolute neutrophil count. In severe burn patients, IG percent stayed elevated even when total white count was low or normal, identifying infection in patients who would have looked unremarkable on a standard CBC (complete blood count). In septic arthritis, the related delta neutrophil index outperformed CRP, ESR (erythrocyte sedimentation rate), white count, and procalcitonin (a bacterial infection marker).
The takeaway: IG captures something specific. It reflects how hard your bone marrow is being pushed, in a way that aggregate white blood cell numbers do not. CRP rises later and reflects downstream inflammation. Procalcitonin leans bacterial but takes time. IG can move first.
These ranges come from outpatient and blood-donor studies using Sysmex automated analyzers. They are illustrative orientation, not universal targets. Your lab will likely report different cutpoints, and reference ranges depend heavily on the specific analyzer and the population it was calibrated against.
| Population | Reported Upper Limit | Source |
|---|---|---|
| Healthy adults (blood donors) | Up to about 0.03 x 10^9/L (95th percentile) | Bruegel et al. on Sysmex XE-2100 |
| Adults over 10 years (outpatients) | Up to 0.9% / 70 cells per microliter | Roehrl et al. on 2,400 outpatients |
| Children up to 10 years (outpatients) | Up to 0.3% / 40 cells per microliter | Roehrl et al. on 2,400 outpatients |
| Healthy reference (Monteiro et al.) | 0 to 0.06 x 10^9/L / 0 to 0.63% | Hematology analyzer reference study |
Newborns are a different category entirely. Their IG percent can reach about 5% in the first 48 hours of life, so adult cutoffs do not apply. Sepsis evaluation in neonates requires age-specific norms, and on some analyzers, low rather than high IG counts may signal infection in newborns.
For adults, the practical interpretation looks roughly like this: a value at or near zero is reassuring. A value above 0.5% is worth paying attention to and is often the threshold where studies start finding clinical signal. A value above 2 to 3% in someone who is unwell is a strong signal of significant inflammation or infection and warrants prompt evaluation.
A single IG reading is a snapshot. Because the marker rises and falls quickly with the state of your immune system, the trend tells you more than any one number. If your value drifts upward over multiple draws without an obvious infection, that is a meaningful signal. If you have known chronic inflammation (cirrhosis, fibromyalgia, autoimmune disease) and your IG is climbing, that pattern has been linked to worse outcomes in observational studies.
For active monitoring during illness or treatment, IG is most useful when measured serially. In sepsis, day-three values predict response to antibiotics. After hemadsorption therapy in sepsis, falling IG levels track with improvement and survival. The cadence depends on context: get a baseline when you are well, retest in 3 to 6 months if you are addressing an inflammatory condition, and then at least annually as part of a CBC.
An elevated IG without symptoms is rarely an emergency, but it is a prompt to look further. Pair the result with hs-CRP (high-sensitivity C-reactive protein, a sensitive inflammation marker) and a full CBC with differential to see whether the pattern fits acute inflammation, chronic inflammation, or possible marrow disease.
If your IG is elevated and you have symptoms (fever, pain, fatigue, recent surgery or injury), seek prompt clinical evaluation, ideally with cultures and additional markers like procalcitonin if infection is suspected. If your IG is elevated without symptoms and stays elevated on a repeat draw a few weeks later, talk with a hematologist or your primary physician about ruling out a marrow process. If your IG climbs against a backdrop of known liver disease, heart disease, or another chronic condition, that trend is itself prognostic information your clinician should know about.
IG count is one of the few markers that can flag a sick person before standard labs catch up. It will not replace the conversation with your doctor or the workup that follows a positive result. But for a few extra dollars on top of a routine CBC, you get a more sensitive read on whether your bone marrow is being stressed, and that signal has been validated across sepsis, severe inflammation, and several chronic diseases.
Evidence-backed interventions that affect your Immature Granulocyte Count level
Immature Granulocyte Count is best interpreted alongside these tests.